1,028
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

One year follow-up of participants in a randomised controlled trial of a CBT-based group therapy programme for adolescents diagnosed with ADHD

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 189-197 | Received 19 Sep 2023, Accepted 01 Jan 2024, Published online: 14 Feb 2024

References

  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th edition, DSM-5. Washington (DC): American Psychiatric Publishing.
  • Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948. doi: 10.1176/ajp.2007.164.6.942.
  • Biederman J, Petty CR, Evans M, et al. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304. doi: 10.1016/j.psychres.2009.12.010.
  • Sibley MH, Mitchell JT, Becker SP. Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies. Lancet Psychiatry. 2016;3(12):1157–1165. doi: 10.1016/S2215-0366(16)30190-0.
  • Armstrong D, Lycett K, Hiscock H, et al. Longitudinal associations Between internalizing and externalizing comorbidities and functional outcomes for children with ADHD. Child Psychiatry Hum Dev. 2015;46(5):736–748. doi: 10.1007/s10578-014-0515-x.
  • Franke B, Michelini G, Asherson P, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the ­lifespan. Eur Neuropsychopharmacol. 2018;28(10):1059–1088. doi: 10.1016/j.euroneuro.2018.08.001.
  • Helsedirektoratet. 2016. ADHD Nasjonal faglig retningslinje. Helsedirektoratet. Available from: https://www.helsedirektoratet.no/retningslinjer/adhd#!
  • NICE. 2018. The National Institute for Health and Care Excellence (NICE) guideline on diagnosis and management of ADHD in children, young people and adults. NICE. Available from: https://www.nice.org.uk/guidance/ng87
  • Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383(11):1050–1056. doi: 10.1056/NEJMra1917069.
  • Jangmo A, Stålhandske A, Chang Z, et al. Attention-deficit/hyperactivity disorder, school performance, and effect of medication. J Am Acad Child Adolesc Psychiatry. 2019;58(4):423–432. doi: 10.1016/j.jaac.2018.11.014.
  • Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet. 2020;395(10222):450–462. doi: 10.1016/S0140-6736(19)33004-1.
  • Sibley MH, Bruton AM, Zhao X, et al. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health. 2023;7(6):415–428. doi: 10.1016/S2352-4642(22)00381-9.
  • Coghill D, Banaschewski T, Cortese S, et al. The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD guidelines group (EAGG). Eur Child Adolesc Psychiatry. 2021;32(8):1337–1361. doi: 10.1007/s00787-021-01871-x.
  • Meyer J, Öster C, Ramklint M, et al. You are not alone - adolescents’ experiences of participation in a structured skills training group for ADHD. Scand J Psychol. 2020;61(5):671–678. doi: 10.1111/sjop.12655.
  • Nordby ES, Gilje S, Jensen DA, et al. Goal management training for adults with ADHD - clients’ experiences with a group-based intervention. BMC Psychiatry. 2021;21(1):113. doi: 10.1186/s12888-021-03114-4.
  • Sibley MH, Rodriguez L, Coxe S, et al. Parent-Teen group versus dyadic treatment for adolescent ADHD: what works for whom? J Clin Child Adolesc Psychol. 2020;49(4):476–492. doi: 10.1080/15374416.2019.1585257.
  • Kodal A, Fjermestad K, Bjelland I, et al. Long-term effectiveness of cognitive behavioral therapy for youth with anxiety disorders. J Anxiety Disord. 2018;53:58–67. doi: 10.1016/j.janxdis.2017.11.003.
  • Andersen AC, Sund AM, Thomsen PH, et al. Cognitive behavioural group therapy for adolescents with ADHD: a study of satisfaction and feasibility. Nord J Psychiatry. 2022;76(4):280–286. doi: 10.1080/08039488.2021.1965212.
  • Haugan A-LJ, Sund AM, Young S, et al. Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial. BMC Psychiatry. 2022;22(1):375. doi: 10.1186/s12888-022-04019-6.
  • Nøvik TS, Haugan AJ, Lydersen S, et al. Cognitive-behavioural group therapy for adolescents with ADHD: study protocol for a randomised controlled trial. BMJ Open. 2020;10(3):e032839. doi: 10.1136/bmjopen-2019-032839.
  • World Health Organization. 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organization.
  • Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988. doi: 10.1097/00004583-199707000-00021.
  • Guy W. 1976. ECDEU assesment manual for psychopharmacology. Vol. 76. Rockville (MD): US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
  • Young S, Bramham J. 2012. Cognitive-behavioural therapy for ADHD in adolescents and adults. 2nd ed. Hoboken (NJ) Wiley-Blackwell.
  • DuPaul G, Power T, Anastopoulos A, et al. 1998. ADHD rating scale-IV: checklists, norms, and clinical interpretation. New York (NY): Guilford Press.
  • Döpfner M, Steinhausen H-C, Coghill D, et al. Cross-cultural reliability and validity of ADHD assessed by the ADHD rating scale in a pan-European study. Eur Child Adolesc Psychiatry. 2006;15(S1):i46–i55. doi: 10.1007/s00787-006-1007-8.
  • Coghill D, Seth S. Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the dundee ADHD clinical care pathway. Child Adolesc Psychiatry Ment Health. 2015;9(1):52. doi: 10.1186/s13034-015-0083-2.
  • Shaffer D, Gould MS, Brasic J, et al. A children’s global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228–1231. doi: 10.1001/archpsyc.1983.01790100074010.
  • Jozefiak T, Hanssen-Bauer K, Bjelland I. Måleegenskaper ved den norske versjonen av childrens global assessment scale (CGAS). PsykTestBARN. 2018;1(3):1–14.
  • Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.
  • Schwarzer R, Jerusalem M. Generalized self-efficacy scale. Extreme stress and communitites: Measures in health psychology: A user’s portfolio causal and control beliefs. Windsor, UK: NFER-NELSON; 1995. pp. 159–177.
  • Scholz U, Doña BG, Sud S, et al. Is general self-efficacy a universal construct? Psychometric findings from 25 countries. Eur J Psychol Assess. 2002;18(3):242–251. doi: 10.1027//1015-5759.18.3.242.
  • Achenbach T. 2009). Achenbach system of empirically based assesment (ASEBA): development, findings, theory and applications. Burlington (VT): University of Vermont, Research Center of Children, Youth & Families.
  • Richter J. Preliminary evidence for good psychometric properties of the Norwegian version of the brief problems monitor (BPM). Nord J Psychiatry. 2015;69(3):174–178. doi: 10.3109/08039488.2014.951070.
  • Twisk J, Bosman L, Hoekstra T, et al. Different ways to estimate treatment effects in randomised controlled trials. Contemp Clin Trials Commun. 2018;10:80–85. doi: 10.1016/j.conctc.2018.03.008.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi: 10.1191/1478088706qp063oa.
  • Sibley MH, Shelton CR, Garcia I, et al. Are there long-term effects of behavior therapy for adolescent ADHD? A qualitative study. Child Psychiatry Hum Dev. 2022;54(4):985–996. doi: 10.1007/s10578-021-01294-4.
  • Young S, Khondoker M, Emilsson B, et al. Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis. Psychol Med. 2015;45(13):2793–2804. doi: 10.1017/S0033291715000756.
  • Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816–818. doi: 10.1176/appi.ajp.157.5.816.
  • Sibley MH, Arnold LE, Swanson JM, et al. Variable patterns of remission From ADHD in the multimodal treatment study of ADHD. Am J Psychiatry. 2022;179(2):142–151. doi: 10.1176/appi.ajp.2021.21010032.
  • Biederman J, Fried R, DiSalvo M, et al. Evidence of low adherence to stimulant medication among children and youths With ADHD: an electronic health records study. Psychiatr Serv. 2019;70(10):874–880. doi: 10.1176/appi.ps.201800515.
  • Bramham J, Young S, Bickerdike A, et al. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5):434–441. doi: 10.1177/1087054708314596.